Asthma and COPD Drug Market

The global Asthma and COPD Drug market was valued at US$ 12930 million in 2022 and is projected to reach US$ 15050 million by 2030, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.
Asthma and COPD Drug Market aims to provide a comprehensive presentation of the global market for Asthma and COPD Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma and COPD Drug. Asthma and COPD Drug Market contains market size and forecasts of Asthma and COPD Drug in global, including the following market information:

• Global Asthma and COPD Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global Asthma and COPD Drug Market Sales, 2018-2023, 2024-2030, (MT)
• Global top five Asthma and COPD Drug companies in 2022 (%)

The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.
We surveyed the Asthma and COPD Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Asthma and COPD Drug Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Asthma and COPD Drug Market Segment Percentages, by Type, 2022 (%)

• Bronchodilators
• Anti-inflammatory Drugs
• Monoclonal Antibodies
• Combination Drugs

Global Asthma and COPD Drug Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Asthma and COPD Drug Market Segment Percentages, by Application, 2022 (%)

• Asthma
• COPD

Global Asthma and COPD Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Asthma and COPD Drug Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Asthma and COPD Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Asthma and COPD Drug revenues share in global market, 2022 (%)
Key companies Asthma and COPD Drug sales in global market, 2018-2023 (Estimated), (MT)
Key companies Asthma and COPD Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Boehringer Ingelheim
• GlaxoSmithKline
• Merck and Co
• Novartis AG
• AstraZeneca
• F. Hoffmann-La Roche

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Asthma and COPD Drug, market overview.
• Chapter 2: Global Asthma and COPD Drug market size in revenue and volume.
• Chapter 3: Detailed analysis of Asthma and COPD Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Asthma and COPD Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Asthma and COPD Drug capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy